We are live on ! Find out more
VASO

VASOMEDICAL INC
VASO

Delisted

VASO was delisted on the 25th of May, 2006.

Back to rankings

2 hedge funds and large institutions have $7K invested in VASOMEDICAL INC in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

85% less capital invested

Capital invested by funds: $48K → $7K (-$41K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NAMP
NorthStar Asset Management (Pennsylvania)
Pennsylvania
-$26.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
NAMP
1
NorthStar Asset Management (Pennsylvania)
Pennsylvania
$6K -$26.5K -306,250 -82%
WSC
2
Wellington Shields & Co
New York
$1K – – –

VASO Hedge Fund Activity: Q1 2017 in Review

2 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in VASOMEDICAL INC (VASO) for Q1 2017, worth a combined $7K — down 85% from $48K a quarter earlier.

Fund positioning in VASO was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was NorthStar Asset Management (Pennsylvania), cutting an estimated $26.5K.

  • 2 institutional investors held VASOMEDICAL INC (VASO) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $7K of VASOMEDICAL INC stock for Q1 2017, down 85% quarter-over-quarter.
  • 0 funds opened new VASOMEDICAL INC positions in Q1 2017 and 0 closed out.
  • The largest VASOMEDICAL INC seller in Q1 2017 was NorthStar Asset Management (Pennsylvania), an estimated $26.5K sold.

Based on aggregated 13F filings for Q1 2017.